The importance of the influence of high blood pressure on the general quality of life can hardly be overestimated. According to the results of studies based on the information gathered as of the date of 2008, 40% of all adults aged 25 and over have noticeable problems with raised blood pressure. Is this condition dangerous? Precisely speaking, the obtained statistical data show that this problem causes 12.8% of all deaths. What is most important in the context of ED is that most severe circulatory conditions tend to develop mainly in men aged 45 and over, which coincides with the frequency of ED development in the worldwide population.
In this case, what are the effects of chronic hypertension on the status of the erectile response? Firstly, increased blood pressure damages almost all major arteries and significantly limits the blood flow to the penile tissues, which eventually leads to erectile dysfunction. Secondly, chronic cardiovascular illnesses promote the development of atherosclerosis, which is a significant factor that makes it impossible to achieve an erection.
Thus, a comprehensive therapy of ED is possible only in the context of a general medical strategy aimed at the decrease of risks connected with the development of cardiovascular troubles and scrupulous treatment of the already diagnosed hypertension conditions. Once such risks are minimized, patients may start increasing the quality of their sexual life by taking an appropriate ED therapeutic agent, preferably an efficient and safe drug, such as Tadalafil.
Efficiency of Tadalafil in patients with hypertension
In compliance to the data from a great number of clinical trials that have been conducted among the general population of adult circulatory patients with ED for a prolonged period, the conclusion on the safety of the medication is reliable. Is the medication safe for patients that suffer from high blood pressure? Though this issue has been controversial for a while, it is now fully answered.
In general, the established incidence of side effects and involved negative reactions is not increased in adult men with circulatory illnesses who take Tadalafil. The conducted meta-analysis shows that this incidence is similar to the values obtained for a general population of adult patients and thus proves the drug’s safety.
The ideal model drug for the hypertension therapy should have positive effect on the circulatory system or at least provide zero probability of a negative outcome after its prolonged use. In view of this, there arises a new question: is Tadalafil efficient enough to allow its use in hypertension patients in place of various alternatives? Although a clinical status of each hypertension patient requires individual consideration of professional health advisors, a generally appropriate answer to this question is affirmative. The medication allows the maintenance of a good quality of life of the patients from said category when taken with necessary precautions.
In addition, since men with hypertension tend to develop some type of ED throughout the period of ten-fifteen years of the chronic illness, the periodic use of the drug aimed at sustaining normal erectile response should be considered rather a normal situation that a clinical exception. Given that the drug causes no noticeable troubles in such patients when taken either episodically or regularly, its systemic ED treatment effect is more than beneficial.
